Drivers of variation in postpartum opioid prescribing across hospitals participating in a statewide maternity care quality collaborative
Birth · 2024
DOI: 10.1111/birt.12809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth, 2024. Verfasst von Alex F Peahl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Practice Patterns, Physicians', Postpartum Period. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: FDA HHS, U.S. Food and Drug Administration, Michigan Department of Health and Human Services.
Abstract (Originalsprache)
Background
We describe variation in postpartum opioid prescribing across a statewide quality collaborative and assess the proportion due to practitioner and hospital characteristics.
Methods
We assessed postpartum prescribing data from nulliparous, term, singleton, vertex births between January 2020 and June 2021 included in the clinical registry of a statewide obstetric quality collaborative funded by Blue Cross Blue Shield of Michigan. Data were summarized using descriptive statistics. Mixed effect logistic regression and linear models adjusted for patient characteristics and assessed practitioner‐ and hospital‐level predictors of receiving a postpartum opioid prescription and prescription size. Relative contributions of practitioner and hospital characteristics were assessed using the intraclass correlation coefficient.
Results
Of 40,589 patients birthing at 68 hospitals, 3.0% (872/29,412) received an opioid prescription after vaginal birth and 87.8% (9812/11,177) received one after cesarean birth, with high variation across hospitals. In adjusted models, the strongest patient‐level predictors of receiving a prescription were cesarean birth (aOR 899.1, 95% CI 752.8–1066.7) and third−/fourth‐degree perineal laceration (aOR 25.7, 95% CI 17.4–37.9). Receiving care from a certified nurse‐midwife (aOR 0.63, 95% CI 0.48–0.82) or family medicine physician (aOR 0.60, 95%CI 0.39–0.91) was associated with lower prescribing rates. Hospital‐level predictors included receiving care at hospitals with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan, USA.
- School of Nursing, University of Michigan, Ann Arbor, Michigan, USA.
- Medical School, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Hsou Mei Hu
Förderung
- FDA HHS
- U.S. Food and Drug Administration
- Michigan Department of Health and Human Services
- NIDDK NIH HHS
- AHRQ HHS
- NIH HHS
- Blue Cross Blue Shield of Michigan Foundation
- NICHD NIH HHS
Zitieren
APA
Peahl, A. F., Low, L. K., Langen, E. S., Moniz, M. H., Aaron, B., Hu, H. M., Waljee, J., & Townsel, C. (2024). Drivers of variation in postpartum opioid prescribing across hospitals participating in a statewide maternity care quality collaborative. Birth. https://doi.org/10.1111/birt.12809
Vancouver
Peahl AF, Low LK, Langen ES, Moniz MH, Aaron B, Hu HM, et al. Drivers of variation in postpartum opioid prescribing across hospitals participating in a statewide maternity care quality collaborative. Birth. 2024. doi:10.1111/birt.12809
BibTeX
@article{Peahl2024,
author = {Peahl, Alex F and Low, Lisa Kane and Langen, Elizabeth S and Moniz, Michelle H and Aaron, Bryan and Hu, Hsou Mei and Waljee, Jennifer and Townsel, Courtney},
title = {Drivers of variation in postpartum opioid prescribing across hospitals participating in a statewide maternity care quality collaborative},
journal = {Birth},
year = {2024},
doi = {10.1111/birt.12809}
}
EUVIMED